Patient experiences of participation in a radical thoracic surgical trial: findings from the Mesothelioma and Radical Surgery Trial 2 (MARS 2)
Abstract Background The Mesothelioma and Radical Surgery Trial (MARS 2) aims to evaluate a surgical procedure by comparing chemotherapy and surgery against chemotherapy alone. The pilot study for MARS 2 evaluated the viability of recruitment. Challenges have been reported in conducting clinical rese...
Main Authors: | Clare Warnock, Karen Lord, Bethany Taylor, Angela Tod |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-019-3692-x |
Similar Items
-
Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial
by: Dean A. Fennell, et al.
Published: (2022-06-01) -
Investigational approaches for mesothelioma
by: Veerle F Surmont, et al.
Published: (2011-08-01) -
Modern management of malignant pleural mesothelioma
by: Patel SC, et al.
Published: (2016-05-01) -
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study
by: Takaya Ikeda, et al.
Published: (2020-07-01) -
Impact of relatively new chemotherapeutic agents on the outcome of Egyptian patients with advanced malignant pleural mesothelioma
by: Gaafar R, et al.
Published: (2014-08-01)